Intrinsiqs

Is Incyte Corporation overvalued?

Incyte Corporation (INCY) looks undervalued — trading about 22% below its fair value.

Undervalued
Current price $123.89 Fair value $150.61
Price
$123.89
Fair value
$150.61
Current P/E
19.3
Normal P/E
23.5
Market cap
$25.11B
Dividend yield
0.0%
Return on equity
29.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares INCY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated